Titre :
  • Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Auteur : Ingle, James N ; Tu, D ; Pater, Joseph L ; Muss, Hyman B ; Martino, S ; Robert, Nicholas J ; Piccart-Gebhart, Martine ; Castiglione, Monica ; Shepherd, L ; Pritchard, Kathleen ; Livingston, Robert ; Davidson, Nancy E ; Norton, Larry ; Perez, E A ; Abrams, Jeffrey S ; Cameron, David A ; Palmer, Michael J ; Goss, Paul E
Informations sur la publication : Annals of oncology, 19, 5, (page 877-882)
Statut de publication : Publié, 2008-05
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Extended adjuvant therapy
Intent-to-treat
Letrozole
Mots-clés MeSH : Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Hormonal -- therapeutic use
Aromatase Inhibitors -- administration & dosage
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Double-Blind Method
Estrogens
Humans
Kaplan-Meiers Estimate
Lymphatic Metastasis
Neoplasms, Hormone-Dependent -- drug therapy
Neoplasms, Second Primary -- drug therapy
Neoplasms, Second Primary -- epidemiology
Nitriles -- administration & dosage
Nitriles -- therapeutic use
Patient Acceptance of Health Care
Placebos
Postmenopause
Progesterone
Proportional Hazards Models
Recurrence
Tamoxifen -- therapeutic use
Triazoles -- administration & dosage
Triazoles -- therapeutic use
Note : Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdm566
info:pii/mdm566
info:pmid/18332043